09:38 AM EST - Microbix Biosystems Inc. : Announces that its quality assessment products are supporting a testing program for Human Papilloma Virus using molecular diagnostic technology at Dublin’s The Coombe Hospital, in the Republic of Ireland, an EU member-state. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.29.
